Cargando…
Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis
An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO) significantly slowed functional decline in a randomized, placebo‐controlled, phase 2 trial in ALS (CENTAUR). Herein we report results of a long‐term survival analysis of participants in CENTAUR. In CENT...
Ejemplares similares
-
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
por: Paganoni, Sabrina, et al.
Publicado: (2022) -
The centaur's dilemma: national security law for the coming AI revolution
por: Baker, James E
Publicado: (2020) -
The centaur's smile : the human animal in early Greek art
por: Padgett, J. Michael -
Centaur antibodies: Engineered chimeric equine-human recombinant antibodies
por: Rosenfeld, Ronit, et al.
Publicado: (2022) -
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
por: Pattee, Gary L., et al.
Publicado: (2014)